Clinical Trials
4 trialsNCT03339843 2024-03-15
MiMe-A
Jules Bordet Institute
Phase 2 Completed
NCT00101972 2022-02-22
RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma
MacroGenics
Phase 1 Completed
NCT00633789 2015-10-09
Phase II Study of Brivanib (BMS-582664) to Treat Multiple Tumor Types
Bristol-Myers Squibb
Phase 2 Completed
NCT00004178 2011-06-10
Gene Therapy in Treating Patients With Cancer
Roger Williams Medical Center
Phase 1 Completed